Skip to main content

Advertisement

Log in

Interferon-alpha (Intron A) upregulates urokinase-type plasminogen activator receptor gene expression

  • Original Article
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

The regulation of urokinase plasminogen activator receptor (uPAR) gene expression by interferon-alpha (IFN-α, or Intron A) and interferon-gamma (IFN-γ) was studied in a HCT116 colon cancer cell line. uPAR mRNA levels were increased in a dose- and time-dependent manner in cells stimulated with IFN-α or IFN-γ. uPAR protein levels reflected IFN-α and IFN-γ induction of uPAR mRNA production. Cycloheximide, a protein synthesis inhibitor, also induced uPAR mRNA accumulation either alone or in combination with IFN-α or IFN-γ, suggesting that the effect on uPAR mRNA levels activated by IFN-α or IFN-γ does not require de novo protein synthesis. Both sodium butyrate and amiloride inhibited the uPAR mRNA levels induced by IFN-α or IFN-γ. These results may provide useful information for the treatment of patients receiving IFN-α or IFN-γ.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Electronic Publication

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wu, S., Murrell, G.A. & Wang, Y. Interferon-alpha (Intron A) upregulates urokinase-type plasminogen activator receptor gene expression. Cancer Immunol Immunother 51, 248–254 (2002). https://doi.org/10.1007/s00262-002-0275-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-002-0275-5

Navigation